Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by

Linhua Liu1, Yiguo Jiang, Hongyu Zhang

  • 1Institute for Chemical Carcinogenesis, State Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou 510182, PR China.

Life Sciences
|December 17, 2009
PubMed
Abstract

Insights

MicroRNA-494 (miR-494) acts as a micro-oncogene in benzo(a)pyrene-induced lung cancer, regulating PTEN expression. Targeting miR-494 offers a potential gene therapy strategy for lung carcinogenesis.

Area of Science:

  • Molecular biology
  • Cancer research
  • Gene regulation

Background:

  • Benzo(a)pyrene is a carcinogen that can induce malignant transformation in human bronchial epithelial cells.
  • MicroRNAs play crucial roles in gene regulation and are implicated in various diseases, including cancer.

Purpose of the Study:

  • To investigate the role of miR-494 in anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide (anti-BPDE)-transformed 16HBE cells.
  • To identify the target gene regulated by miR-494 and elucidate its function in carcinogenesis.

Main Methods:

  • Quantitative real-time PCR (QRT-PCR) to measure miR-494 expression.
  • Western blot and QRT-PCR to assess PTEN mRNA and protein levels.
  • Functional assays including cell apoptosis, soft agar growth, and cell motility analyses following miR-494 modulation.

Main Results:

  • miR-494 expression was upregulated, and PTEN protein was downregulated in anti-BPDE-transformed 16HBE cells.
  • miR-494 directly targets PTEN, regulating its post-transcriptional expression.
  • Modulation of miR-494 affected cell apoptosis, proliferation, and motility, indicating its role in malignant transformation.

Conclusions:

  • MiR-494 functions as a micro-oncogene in anti-BPDE-induced lung carcinogenesis by downregulating PTEN.
  • MiR-494 represents a potential therapeutic target for gene therapy in lung cancer.